Zydus Hospital teams up with Roche Diagnostics India, becoming the first in Gujarat to bring the cutting-edge Elecsys® test for early diagnosis of Alzheimer's Disease

Around 8.8 million individuals over the age of 60 live with dementia in India, with Alzheimer's disease (AD) being one of the most common types.

Zydus Hospital, Ahmedabad, partners with Roche Diagnostics India, becoming the first in Gujarat to introduce the Elecsys® Alzheimer's Disease CSF test for early diagnosis. Elecsys® is an FDA-approved, cutting-edge, automated test that analyses biomarkers in the cerebrospinal fluid (CSF) to provide reliable, safe, and accurate results. This test can accurately detect the onset of AD up to 10 years before any symptom onset, drastically improving patient outcomes.